Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL738903 | 0.80 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL738902 | 0.80 | ALDH1A1 (0.36) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL763408 | 0.80 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AATMDGAT1 | |
| SCHEMBL6518949 | 0.77 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AATMDGAT1 | |
| SCHEMBL10192467 | 0.77 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AATMDGAT1 | |
| SCHEMBL17202936 | 0.75 | ALDH1A1 (0.47) | ALDH1A1MEN1KMT2AATMDGAT1 | |
| Hydrochloric Acid SCHEMBL8306028 | 0.74 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2AATMDGAT1 | |
| SCHEMBL1800282 | 0.72 | ALDH1A1 (0.42) | ALDH1A1MEN1KMT2AATML3MBTL1 | |
| SCHEMBL16803412 | 0.72 | ALDH1A1 (0.37) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL3831391 | 0.71 | HDAC6 (0.45) | ALDH1A1MEN1KMT2AL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138350-B2 | N′-cyano-N-halogenalkylimidamide derivatives | BAYER CROPSCIENCE AG (DE) | 2012-03-20 | — | — | US | disclosed |
| US-20100048646-A1 | N'-Cyano-N-Halogenalkylimidamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048646-A1 | N'-Cyano-N-Halogenalkylimidamide Derivatives | NCLN, NISCH, DDT | ALDH1A1 3834/4885MEN1 3932/4885KMT2A 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.